Cancer Channel
Related Channels

Indications for Marinol

The U.S. Food and Drug Administration (FDA) has approved Marinol® (dronabinol) for the following indications (uses):
  • Appetite loss (known medically as anorexia) associated with weight loss in people with AIDS (acquired immunodeficiency syndrome)
  • Nausea and vomiting from cancer chemotherapy, when other treatments have not worked.
This medication is believed to work by binding to certain receptors in the central nervous system. In clinical studies, the combination of Marinol and prochlorperazine (Compazine®) was shown to reduce chemotherapy-induced nausea and vomiting more than the use of prochlorperazine alone.
Marinol comes in the form of a capsule, and is taken anywhere from two to six times a day, depending on the condition being treated, side effects, and other factors.
(Click Marinol Uses to learn more about when this medication is indicated as a treatment for nausea, vomiting, and appetite loss. This article explains in more detail how Marinol works and whether children can take it.)
The Zen of Cancer Caregiving - Recharge Your Batteries!
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.